Dr. Peter M. Shepard, MD

Dr. Shepard practices at Central Oregon ENT - Ear Nose Throat and Facial Plastic Surgey in Bend, Oregon.

Dr. Shepard's NPI, 1023051232, was assigned on June 14, 2006. Dr. Shepard holds New Mexico license MD2009-0111.

Dr. Shepard's primary practice is Central Oregon ENT - Ear Nose Throat and Facial Plastic Surgey, at 2450 NE Mary Rose Pl, Bend, OR 97701 in Deschutes County. The practice phone is (541) 312-6799.

Dr. Shepard's primary practice is Central Oregon ENT - Ear Nose Throat and Facial Plastic Surgey in Bend, Oregon. Dr. Shepard is also affiliated with St. Charles Bend. The medical group on file is Central Oregon ENT. Dmand AI also links Dr. Shepard to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shepard practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Shepard's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Shepard is licensed in New Mexico.

CMS data shows 1,948 Medicare services from Dr. Shepard across 12 procedure codes in 2024, for 377 Medicare patients. Medicare paid $74,540 for them. Every service was in an office.

CMS counts 377 Medicare patients who saw Dr. Shepard in 2024. The largest group is 65 to 74, with 186 patients. 68% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shepard's median patient age at 63, with 51% women.

In 2024, Dr. Shepard wrote 246 Medicare Part D claims for 104 patients. 99% of them were for generic drugs. CMS names the drug for 182 of them, across 8 drugs with 11 or more claims each, at $1,953 in total drug cost. In 2023, CMS named 194 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Shepard for performance year 2024, reported as part of a group. Dr. Shepard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shepard as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 100 general payments to Dr. Shepard from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Medtronic, Inc. paid the most, $2,593.